BMJ

See the following -

IBM Pitched Its Watson Supercomputer as a Revolution in Cancer Care. It’s Nowhere Close

Casey Ross | STAT | September 5, 2017

It was an audacious undertaking, even for one of the most storied American companies: With a single machine, IBM would tackle humanity’s most vexing diseases and revolutionize medicine. Breathlessly promoting its signature brand — Watson — IBM sought to capture the world’s imagination, and it quickly zeroed in on a high-profile target: cancer. But three years after IBM began selling Watson to recommend the best cancer treatments to doctors around the world, a STAT investigation has found that the supercomputer isn’t living up to the lofty expectations IBM created for it. It is still struggling with the basic step of learning about different forms of cancer...

Read More »

Initiative for Open Citations Making Great Progress

It is enormously satisfying when a good idea captures the imagination and takes off and that’s precisely what happened with the Initiative for Open Citations (I4OC) over the past 6 months. Citations are the way that researchers communicate how their work builds on and relates to the work of others and they can be used to trace how a discovery spreads and is used by researchers in different disciplines and countries. Creating a truly comprehensive map of scholarship, however, relies on having a curated machine-readable database of citation information, where the provenance of every citation is clear and reusable. With the launch of I4OC that map, and the potential for anyone to use it to explore the scholarly landscape, comes much closer...

Read More »